Journal Articles
Permanent URI for this collectionhttps://mro.massey.ac.nz/handle/10179/7915
Browse
Search Results
Item He Kāinga Oranga: reflections on 25 years of measuring the improved health, wellbeing and sustainability of healthier housing(Taylor and Francis, on behalf of Te Aparangi, The Royal Society of New Zealand, 2023-02-06) Howden-Chapman P; Crane J; Keall M; Pierse N; Baker MG; Cunningham C; Amore K; Aspinall C; Bennett J; Bierre S; Boulic M; Chapman R; Chisholm E; Davies C; Fougere G; Fraser B; Fyfe C; Grant L; Grimes A; Halley C; Logan-Riley A; Nathan K; Olin C; Ombler J; O’Sullivan K; Pehi T; Penny G; Phipps R; Plagman M; Randal E; Riggs L; Robson B; Ruru J; Shaw C; Schrader B; Teariki MA; Telfar Barnard L; Tiatia R; Toy-Cronin B; Tupara H; Viggers H; Wall T; Wilkie M; Woodward A; Zhang WThis paper reflects on the influences and outcomes of He Kāinga Oranga/Housing and Health Research Programme over 25 years, and their impact on housing and health policy in Aotearoa and internationally. Working in partnership particularly with Māori and Pasifika communities, we have conducted randomised control trials which have shown the health and broad co-benefits of retrofitted insulation, heating and remediation of home hazards, which have underpinned government policy in the Warm Up NZ-Heat Smart programme and the Healthy Homes Standards for rental housing. These trials have been included as evidence in the WHO Housing and Health Guidelines and led to our designation as a WHO Collaborating Centre on Housing and Wellbeing. We are increasingly explicitly weaving Māori frameworks, values and processes with traditional Western science.Item Retrofitting home insulation reduces incidence and severity of chronic respiratory disease(John Wiley and Sons, Ltd, 21/08/2022) Fyfe C; Barnard LT; Douwes J; Howden-Chapman P; Crane JTo assess whether retrofitting home insulation can reduce the risk of respiratory disease incidence and exacerbation, a retrospective cohort study was undertaken using linked data from a national intervention program. The study population was made up of 1 004 795 residents from 205 001 New Zealand houses that received an insulation subsidy though a national Energy Efficiency and Conservation Authority program. A difference-in-difference model compared changes in the number of prescriptions dispensed for respiratory illness post- insulation to a control population over the same timeframe. New prescribing of chronic respiratory disease medication at follow-up was used to compare incidence risk ratios between intervention and control groups. Chronic respiratory disease incidence was significantly lower in the intervention group at follow-up: odds ratio 0.90 (95% CI: 0.86-0.94). There was also a 4% reduction in medication dispensed for treating exacerbations of chronic respiratory disease symptoms in the intervention group compared with the control group: relative rate ratio (RRR) 0.96 (95% CI: 0.96-0.97). There was no change in medication dispensed to prevent symptoms of chronic respiratory disease RRR: 1,00 (95% CI: 0.99-1.00). These findings support home insulation interventions as a means of improving respiratory health outcomes.
